return equiti ttm
market nois galvan impella commun action acceler
growth might still take time take right step
announc fiscal third quarter result line pre-announce
earli januari time announc came street
expect third-quart sale neg impact two data
present last year american heart associ aha scientif session
meet novemb lead growth basi point
estim time pre-announce detail specif quarter
weak see pre-announce note third quarter neg affect aha
data remain believ timelin sustain growth potenti delay
third-quart result line januari preliminari announc
manag provid key updat quarterli earn call specif
manag updat guidanc low end previous provid
rang given continu weak core busi month januari larg flat
year-over-year though sequenti decemb impli continu headwind
aha data littl benefit on-going commerci initi remaind
quarter manag also provid new detail clinic pipelin highlight
multipl rct effort design size rigor need class societi guidelin
recommend taken togeth updat on-going education/train initi
ongoing/upcom product launch sever reason remain posit
abiom long-term growth trajectori believ abiom achiev near-term
guidanc expect believ upsid remain limit initi take foot
follow revenu slowdown earlier year last quarter reacceler
seem though growth expect firm recent aha data
present like take time effort manag sale
organ get better sens impact clinician behavior
believ near-term upsid limit encourag manag dedic
field train educ initi well willing invest sever new
could potenti chang standard care hrpci shock stemi
said stock opinion remain someth show-m stori abiom
demonstr stabil start reacceler growth well posit larg
under-penetrated market clinic valid solut believ posit
compani solid long-term growth share trade time calendar revenu
estim million growth time calendar ep estim
rate stock outperform
make number cardiac-assist devic treat acut heart failur compani portfolio
highlight impella product first percutan catheter-bas cardiac assist devic
conclus stock thought
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
updat clinic roadmap ramp offens manag establish definit roadmap
upcom clinic trial focu rigor random control trial capabl chang standard
care receiv class guidelin recommend within multipl treatment opportunitiesnam hrpci cardiogen
shock stemi arguabl extens clinic support impella today rct data consid
gold standard cardiolog limit less clear physician would like end willing
execut run sever impella rct meaning event sinc potenti convert
clinicians/increas user util chang societi guidelin standard care
stemi term timelin stemi trial first start enrol decemb patient
enrol patient potenti site run enrol timelin suggest
stemi data still two-plu year trial potenti open market opportun
annual domest stemi patient billion-plu opportun believ enrol mileston could act
protect iv hrpci expect protect iv next trial start enrol expect start within next
year build hrpci treatment protocol fine-tun protect random patient
either impella support plan mechan circulatori support manag specif focus
hrpci patient receiv sinc larger market opportun potenti even harder
popul given complic iabp expect get detail surround size endpoint
protect iv march analyst day may
recov iv shock lastli plan run rct within cardiogen shock recov iv leverag mani
center enrol stemi trial mean time somewhat depend progress stemi
onboard train result time least certain recov iv note shock continu rel
strong momentum growth third quarter demonstr less need sustain
segment growth expect on-going trials/registri like danger trial shock rct denmark nation
cardiogen shock imit support growth eventu readout recov iv trial could chang
guidelin provid posit inflect shock growth futur
altogeth believ posit necessari clinic trial meaning acceler impella
adopt util though like two-plu year away limit near-term benefit
meantim manag stringent focus educ market limit recent aha data present
also remind physician commun impella extens support clinic back includ seven fda
studi five post-market studi plu patient follow registri involv confer call
key opinion leader kol multi-c road show first meet took place week dalla clinician
present renew educ train materi like new initi focus hrpci procedur support
manag also note effort solidifi alreadi strong podium presenc medic meetings/trad show
addit registri databas present includ stringent analysi premier databas present
aha novemb believ medic meet prove solid event reeduc field point
upcom american colleg cardiolog meet march nearest event potenti
remain encourag manag prompt respons field weak continu believ upsid near-term
expect limit sinc initi like requir sever quarter sustain acceler growth
believ hrpci especi requir meaning time effort reacceler hrpci year-over-year given
elect natur procedur subsequ need strong referr network work close
kol help reinvigor hrpci growth provid educ support materi kol still
need educ refer physician potenti network admin rebuild prior referr pattern
believ compani effort appropri acknowledg may take sever quarter meaning impact hrpci
side busi cardiogen shock rel strong year-over-year benefit new product
launch impella arguabl definit clinic benefit decreas mortal encouragingli manag note
shock growth led kol new user leav us increment comfort shock momentum
abil help achiev near-term expect sum expect next sever quarter top-lin
growth neg impact hrpci weak believ cardiogen shock growth allow meet
guidance/expect fiscal potenti fiscal
fiscal guidanc look achiev guid fiscal sale lower end prior million
million rang impli midsingle-digit sequenti declin busi estim slightli slower
intern growth due intern nois caus aha data present particularli germani
fourth-quart impli sequenti declin midsingl digit compar fourth-quart histor
sequenti growth fiscal respect core impella issu began assum aha headwind
persist littl benefit recent market initi product launch believ updat guidanc achiev
base assumpt believ momentum support matur initi
implement sever quarter ago expand sale educ team new data etc help achiev
fiscal guidanc upcom educ initi
initi thought fiscal earli call upsid upcom catalyst potenti mani abiom
recent announc initi like requir least sever quarter play compani multipl catalyst
effort start bear fruit fiscal recal refocus expand commerci organ
follow februari impella rp safeti letter lap month newli hire rep start reach
product level meaning contribut impella growth help compani recent market educ
effort matur expand salesforc also come opportun time roll new impella
pump cardiogen shock well impella cp smartassist impella cp case fiscal year-end
new expand sheath expect lower access profil impella cp expect unit
state end fiscal believ product benefit expand matur salesforc allow
greater impella growth fiscal beyond
near term impella offer design tweak improv long-term support critic cardiogen shock help
drive adopt util within shock someth believ help achiev near-term expect smartassist
new platform offer real-tim nativ heart data better patient manag wean
smartassist metric still earli manag note util tend see notic uptick adopt platform
overal encourag effort look durabl sign growth incorpor benefit
estim
manag provid fiscal guidanc updat estim larg assum aha headwind persist
year factor much benefit matur rep new product launch manag
educ train effort specif estim fiscal sequenti growth
compar histor trend sequenti growth year word
current estim lower histor trend basi point basi point basi point basi
point respect despit start year meaning easier comp fourth quarter histor
versu growth trend give us increas confid abil achiev fiscal number
though look durabl sign acceler call upsid
note also believ reimburs propos schedul expect april could creat uncertainti fiscal
impella drg code cut similar rate last year propos rate expect
fight propos cut past year look detail get closer overal feel
comfort new fiscal estim achiev could potenti upsid estim mani
compani initi start benefit impella adopt util
abiom growth heavili depend continu increas adopt util singl product impella
compani unabl suffici demonstr clinic econom benefit impella growth neg
impact physician curtail use pump near term compani must also refut recent present data
suggest poor outcom impella devic potenti slow growth impella use long
term clinic data collect remain import compani also like need execut pipelin product
capabl support widespread use pump delay inabl execut pipelin product
need regulatori approv well limit long-term growth
newpreviouschang newpreviouschang us impella growth margin margin summari chang modelfisc import disclosur
